Xcout IntelSign inSubscribe

Orion Corporation competitors & alternatives

ORNPPharmaceuticalsFinland

The 12 closest competitors and alternatives to Orion Corporation among pharmaceuticals companies — ranked by similarity to what Orion Corporation actually does, not by market-cap band.

$28.6MMarket cap
3,527Employees
12Competitors listed

Subscribe to see Orion Corporation’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Orion Corporation

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

Orion Corporation at a glance

Orion Corporation is a pharmaceuticals company headquartered in Finland. It is publicly listed (ORNP) with a market capitalisation of $28.6M.

Top 12 Orion Corporation competitors

Ranked by semantic similarity — how close each company is to Orion Corporation by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

住友ファーマ4506 · PharmaceuticalsOsaka, Japan
63% matchPublic

Similar pharmaceuticals company

Sumitomo Pharma Co., Ltd. is a global company involved in the creation, production, and sale of a variety of products, including human pharmaceuticals, food ingredients and additives, and veterinary medicines. Its operations span across Japan, North America, China, and other international territories. The company's pharmaceutical offerings address a broad spectrum of medical needs. These include treatments for conditions such as Parkinson's disease, depression, type 2 diabetes, systemic fungal infections, hypertension, pruritus, chronic obstructive pulmonary disease (COPD), angina pectoris, and arrhythmia. Additionally, they manufacture atypical antipsychotics, antiepileptics, carbapenem antibiotics, gastrointestinal products, and specialized medications for Anderson-Fabry disease. Beyond healthcare, Sumitomo Pharma provides food components and enhancement agents like polysaccharides, along with savory flavorings such as soups and bouillons. The company also supplies chemical raw materials, which encompass pharmaceutical excipients, components for personal care products, substances used in coatings and industrial applications, and electronic materials. Moreover, it produces veterinary therapeutic solutions designed for domestic pets, specifically dogs and cats, as well as for various farm animals, including cattle, swine, poultry, horses, and cultivated fish. To drive innovation, Sumitomo Pharma fosters partnerships with several organizations. These collaborators include Healios K.K., Keio University, RIKEN, the Center for iPS Cell Research and Application, Kyoto University, and Aikomi Co., Ltd. The company also maintains a joint development agreement with SanBio Company Limited, a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd., and a strategic alliance with Roivant Sciences Ltd. Originally established in 1897, the company, headquartered in Osaka, Japan, was known as Sumitomo Dainippon Pharma Co., Ltd. until it adopted its current name, Sumitomo Pharma Co., Ltd., in April 2022. It functions as a subsidiary of Sumitomo Chemical Company, Limited.

Market cap$3.8B
Employees3,123
住友ファーマ competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Orion Corporation and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Orion Corporationand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →